< Back to latest news & events

Event

UPC event in Ireland: Maintaining commercial relevance of your European IP strategy with the new Unified Patent Court system

August 2022

Event date: 6th October 2022

Join HGF in association with Ibec for our networking event and panel discussion exploring the practical ramifications of the Unitary Patent and Unified Patent Court

Date

Thursday 6th October, 2022

Time

6PM

Venue

The Guinness Enterprise Centre (GEC), Dublin

About the event

The patent landscape in Europe is on the brink of the most significant change in a generation; a change that could significantly alter what is the most commercially relevant and cost-effective patent strategy for your business. We invite you to learn more about the strategic considerations and practicalities of the Unitary Patent (UP) and Unified Patent Court (UPC).

Our panellists will discuss:

  • What does this mean for Irish businesses of all sizes and across all sectors for existing European patents and for future IP strategies?
  • What are the advantages and cost benefits of the UP and UPC for Irish businesses; and
  • What steps does Ireland need to take to be able to access the benefits the UPC could bring?
Panellists
  • Naoise Gaffney, Head of Intellectual Property, GH Research and Chair of the Ibec Corporate IP Group
  • Fiona Ryan, Start Up & Entrepreneurship Lecturer, Technological University Dublin and Co-Founder of Colata
  • Joe Doyle, Intellectual Property Manager, Enterprise Ireland
  • Andrew Knox, Lecturer in Biochemistry and Principal Investigator, Technological University Dublin and Founder of MyWorkaway
  • Rachel Fetches, Partner & Head of Law, HGF
  • Marie Walsh, Patent Director, HGF
Ireland and UPC

All Irish businesses will need to make important decisions now about their European patents as the UPC will affect all granted European patents and pending European patent applications, irrespective of the status of the Irish government’s progress towards ratification of the UPC Agreement. Additionally, the European Patent office (EPO) has announced new measures for supporting users in an early uptake of the UP.

Looking forward, there is a significant opportunity for Ireland to enhance its reputation as a hub for end-to-end IP activity, including obtaining and enforcement of IP rights. An Irish Local Division of the Unified Patent Court would support the further expansion of the patent-intensive sectors across the country, creating jobs, benefitting all Irish businesses and boosting Ireland’s innovation performance.

Further, the European UPC’s Central Division must find a new location, instead of London, for the cases it will handle in the chemicals, biopharmaceuticals and medical device sectors. These industries are key contributors to the Irish economy. As an English-speaking, common law jurisdiction, with strong links to the US and the rest of the world, Ireland is well-placed as a location for the Central Division Court which would mean easier access to enforcement of IP rights for Irish-based companies in those sectors.

Latest updates

The Antibody Series #5 | Epitope-defined antibody claims: when “binds to this epitope” becomes a risk of insufficiency

The Boards of Appeal of the EPO (BoA) are the appeal body that reviews decisions made at the EPO; here, they reviewed an appeal in opposition proceedings after the revocation …

Read article

The Deity Shoes case: a question of design activity and the constraints on a designer’s freedom

The footwear brand Deity Shoes sought to enforce their Community Design rights, both registered and unregistered, against Mundorama Confort and Stay Design. However, Mundorama Confort and Stay Design found fault …

Read article

The Antibody Series #4 | pH points in antibody claims: when “same pH ” becomes an addition of matter

The Boards of Appeal of the EPO (BoA) are the appeal body that reviews EPO decisions; in this case, they reviewed a revocation in opposition of a patent relating to …

Read article

The Antibody Series #3 | Antibody code names in claims: why “ACZ885” is not sufficient to define the antibody

The Boards of Appeal of the EPO (BoA) are the appeal body that reviews EPO decisions. In this case, they examined a claim that identified an antibody by an internal …

Read article
Event - 3rd February 2026

HGF Brand & Design Conference 2026

Join us on 3rd February 2026 for HGF’s Brand & Design Conference, the must attend event for in-house legal teams, brand leaders, creatives, and innovators shaping the future of IP. …

Event details

Office Closed Dates December 2025 / January 2026

HGF Office Closed Dates December 2025 / January 2026   UK Thursday 25 and Friday 26 December 2025 CLOSED Thursday 1 January 2026* CLOSED * Friday 2 January 2026 – …

Read article
Event - 14th January 2026

Seminar on The aftermath of G1/24 - has anything changed?

HGF is hosting a The aftermath of G1/24 – has anything changed? Which will be followed by networking, apero, and snacks. The Seminar will be held on Wednesday, 14th January …

Event details

Zombie Fashion Brands

Episode 4 Zombie Fashion Brands  

Read article